|
POM121C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44350000000448E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01090000004245E-06 |
| Normal-vs-Stage2 |
3.500300E-02 |
| Normal-vs-Stage3 |
4.21680000000091E-05 |
| Normal-vs-Stage4 |
6.375300E-04 |
| Stage1-vs-Stage2 |
1.081430E-01 |
| Stage1-vs-Stage3 |
9.710400E-01 |
| Stage1-vs-Stage4 |
7.939400E-01 |
| Stage2-vs-Stage3 |
1.702180E-01 |
| Stage2-vs-Stage4 |
3.229400E-01 |
| Stage3-vs-Stage4 |
8.036800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82748999999482E-05 |
| Normal-vs-AfricanAmerican |
1.138240E-01 |
| Normal-vs-Asian |
1.68117000000079E-05 |
| Caucasian-vs-AfricanAmerican |
2.162600E-01 |
| Caucasian-vs-Asian |
2.792400E-01 |
| AfricanAmerican-vs-Asian |
6.259800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84289999985532E-07 |
| Normal-vs-Female |
4.10379999999932E-05 |
| Male-vs-Female |
8.508100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.95700000005239E-06 |
| Normal-vs-Age(41-60Yrs) |
5.87369999999199E-05 |
| Normal-vs-Age(61-80Yrs) |
7.639900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.446300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.007800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.919400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.956200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.517000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.643400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.953200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.604000E-04 |
| Classical-VS-Follicular |
4.984000E-02 |
| Classical-VS-Other |
3.823500E-02 |
| Classical-VS-Normal |
2.800900E-04 |
| Tall-VS-Follicular |
9.526200E-02 |
| Tall-VS-Other |
4.847200E-01 |
| Tall-VS-Normal |
5.99210000507E-08 |
| Follicular-VS-Other |
2.273200E-01 |
| Follicular-VS-Normal |
5.51069999999987E-05 |
| Other-VS-Normal |
8.374900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.00339999999866E-05 |
| Normal-vs-N1 |
9.8189999999998E-05 |
| N0-vs-N1 |
4.690800E-01 |
|
|
